GIA
MEDP icon

Gladstone Institutional Advisory’s Medpace MEDP Stock Holding History

Gladstone Institutional Advisory’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,423
Closed -$302K – 694
2022
Q4 		$302K Buy
+1,423
New +$284K 0.02% 497

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Gladstone Institutional Advisory's MEDP Position: Q1 2023 in Review

Gladstone Institutional Advisory sold out of Medpace (MEDP) in Q1 2023, closing a stake of 1,423 shares — an estimated $302K sold.

Gladstone Institutional Advisory first reported a position in MEDP in Q4 2022 and held it in 1 quarter. The position peaked at $302K in Q4 2022. 416 funds tracked by Wall St. Rank hold MEDP as of Q1 2023.

  • Gladstone Institutional Advisory reported no remaining Medpace position as of Q1 2023 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 1,423 Medpace shares in Q1 2023, an estimated $302K.
  • Gladstone Institutional Advisory first reported a position in Medpace in Q4 2022 and held it in 1 quarter.
  • Gladstone Institutional Advisory's Medpace position peaked at $302K in Q4 2022.
  • 416 funds tracked by Wall St. Rank held Medpace as of Q1 2023.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2023, filed 12 May 2023.